TOULOUSE, France--(BUSINESS WIRE)--Vexim, the specialist in minimally invasive anatomical restoration of vertebral compression fractures, today announced the CE Marking and the market launch of its 6.5 mm diameter SpineJack® implant, which thus guarantees the technology’s compliance and safety.
Vexim has developed three sizes of its titanium SpineJack® implant:
- a 5 mm diameter model for treating standard-sized vertebrae.
- a 6.5 mm diameter model for treating larger vertebrae (lumbar vertebrae or other vertebrae in larger patients).
- a 4.2 mm diameter model for treating smaller vertebrae (notably thoracic vertebrae or other vertebrae in smaller patients).
“We are delighted to have obtained the CE mark for our 6.5 mm implant; it constitutes an essential milestone for rolling out our pre-sales strategy in Europe with a range of target populations. The CE Mark guarantees that our technology has the levels of reliability and safety that our customers demand and expect from us”, emphasized Vexim CEO Bruce de la Grange.
Toulouse-based Vexim is an innovative medical device (Med Tech) company that was founded in February 2006 with support from Truffle Capital. The company was also subsequently financed by Banexi Ventures in September 2006 and received financial support from Oséo (the French state innovation agency) in 2009. Vexim specializes in the development of minimally invasive solutions for the treatment of vertebral fractures - notably the SpineJack®, a system used for anatomically accurate restorative surgery. In July 2009, the company signed an exclusive agreement with Stryker EMEA for distribution of the SpineJack® in Germany, the UK, Austria and Ireland. SpineJack® is CE marked and has been on the market since mid-2010. The company currently has 23 employees. For more information, visit www.vexim.com.